Novo Nordisk A/S trailing returns
Novo Nordisk A/S's 10-year annualized return is +8.9% per year (+134.7% cumulative). How Novo Nordisk A/S (NVO) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through September 18, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-09-18. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +0.1% | |
| 5 days | — | +0.4% | |
| 1 month | — | -5.4% | |
| YTD | — | -10.8% | |
| 1 year | -26.6% | -26.6% | |
| 5 years | -0.9% | -4.6% | |
| 10 years | +8.9% | +134.7% | |
| 20 years | +15.1% | +1557.0% | |
| Since inception (1981) | +14.0% | +37304.8% |
Growth of NVO
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-09-18). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from NVO's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Novo Nordisk A/S's 10-year return?
- Over the last 10 years, Novo Nordisk A/S (NVO) returned about +8.9% a year annualized (+134.7% cumulative total return).
- What is Novo Nordisk A/S's 20-year annualized return?
- Over the last 20 years, Novo Nordisk A/S (NVO) compounded at about +15.1% a year (+1557.0% cumulative).
- What is Novo Nordisk A/S's return since inception?
- Since 1981, Novo Nordisk A/S (NVO) has compounded at about +14.0% a year — +37304.8% in total.